Characterization of human CD4+ T-cell clones recognizing conserved and variable epitopes of the Lassa virus nucleoprotein

Journal of Virology

Volumn 74, Issue 5, 2000, Pages 2186-2192

  Ter Meulen, Jan ^a,b   Badusche, Marlis ^a   Kuhnt, Kristiane ^a   Doetze, Andrea ^a   Satoguina, Judith ^a   Marti, Thomas ^a   Loeliger, Cornelius ^c   Koulemou, Kekoura ^d   Koivogui, Lamine ^d   Schmitz, Herbert ^a   Fleischer, Bernhard ^a   Hoerauf, Achim ^a  

^a BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

^b EPICENTRE   (France)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^d Projet sur le Rech de Fievres H ^*  (Guinea)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; EPITOPE; VIRUS PROTEIN;

ANTIBODY RESPONSE; ANTIGEN RECOGNITION; ARTICLE; CELLULAR IMMUNITY; HUMAN; HUMAN CELL; LASSA VIRUS; LYMPHOCYTE CLONE; NONHUMAN; PRIORITY JOURNAL; SEROLOGY; T LYMPHOCYTE; VACCINATION; VIRUS INFECTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMINO ACID SEQUENCE; ANTIBODIES, VIRAL; CD4-POSITIVE T-LYMPHOCYTES; CLONE CELLS; CLONING, MOLECULAR; EPITOPE MAPPING; ESCHERICHIA COLI; FEMALE; GENES, VIRAL; GUINEA; HUMANS; INTERFERON TYPE II; LASSA FEVER; LASSA VIRUS; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NUCLEOPROTEINS; PEPTIDES; RECOMBINANT PROTEINS; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY, AMINO ACID; SEROEPIDEMIOLOGIC STUDIES;

EID: 0033953754     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.5.2186-2192.2000     Document Type: Article

References (33)

1. Auperin, D. D., J. J. Esposito, J. V. Lange, S. P. Bauer, J. Knight, D. R. Sasso, and J. B. McCormick. 1988. Construction of a recombinant vaccinia virus expressing the Lassa virus glycoprotein gene and protection of guinea pigs from a lethal Lassa virus infection. Virus Res. 9:233-248.
2. Butz, E. A., and M. J. Bevan. 1998. Massive expansion of antigen-specific CD8 + T cells during an acute virus infection. Immunity 8:167-175.
3. Clegg, J. C. S., and G. Lloyd. 1987. Vaccinia recombinant expressing Lassa virus internal nucleocapsid protein protects guinea pigs against Lassa fever. Lancet ii:186-188.
4. Clegg, J. C. S. 1992. Current progress towards vaccines for arenavirus-caused diseases. Vaccine 10:89-95.
5. Doetze, A., K. D. Erttmann, M. Y. Gallin, B. Fleischer, and A. Hoerauf. 1997. Production of hoth IFN-γ and IL-5 by Onchocerca volvulus S1 antigen specific CD4+ T cells from putatively immune individuals. Int. Immunol. 9:721-729.
6. Erlich, H., T. Bugawan, A. B. Begovich, S. Scharf, R. Griffith, R. Saiki, R. Higuchi, and P. S. Walsh. 1991. HLA-DR, DQ and DP typing using PCR amplification and immobilized probes. Eur. J. Immunogenet. 18:33-55.
7. Fisher-Hoch, S. P., J. B. McCormick, D. Auperin, B. G. Brown, M. Castor, G. Perez, S. Ruo, A. Conaty, L. Brammer, and S. Bauer. 1989. Protection of rhesus monkeys from fatal Lassa fever by vaccination with a recombinant vaccinia virus containing the Lassa virus glycoprotein gene. Proc. Natl. Acad. Sci. USA 86:317-321.
8. Hufert, F. T., W. Lüdke, and H. Schmitz. 1989. Epitope mapping of Lassa virus nucleoprotein using monoclonal anti-nucleocapsid antibodies. Arch. Virol. 106:201-212.
9. Jahrling, P. B., J. D. Frame, J. B. Rhoderick, and M. H. Monson. 1985. Endemic Lassa fever in Liberia. IV. Selection of optimally effective plasma for treatment by passive immunization. Trans. R. Soc. Trop. Med. Hyg. 79:380-384.
10. Jahrling, P. B., and C. J. Peters. 1986. Serology and virulence diversity among Old-World arenaviruses, and the relevance to vaccine development. Med. Microbiol. Immunol. 175:165-167.
11. Johnson, K. M., J. B. McCormick, P. A. Webb, E. S. Smith, L. H. Elliot, and I. J. King. 1987. Clinical virology of Lassa fever in hospitalized patients. J. Infect. Dis. 155:456-463.
12. Kamperschroer, C., and D. G. Quinn. 1999. Quantification of epitope-specific MHC class-II-restricted T cells following lymphocytic choriomeningitis virus infection. Cell. Immunol. 193:134-145.
13. Kiley, M. P., J. V. Lange, and K. M. Johnson. 1979. Protection of rhesus monkeys from Lassa virus by immunization with a closely related arenavirus. Lancet ii:738.
14. Kurane, I., L. Zeng, M. A. Brinton, and F. A. Ennis. 1998. Definition of an epitope on NS3 recognized by human CD4+ cytotoxic T lymphocyte clones cross-reactive for Dengue virus types 2, 3, and 4. Virology 240:169-174.
15. Lampson, L., and R. Levy. 1980. Two populations of Ia-like antigens on a human B cell line. J. Immunol. 125:293-299.
16. + T-cell clone specific for an envelope glycoprotein of Lassa virus. J. Virol. 67:3497-3506.
17. Marti, T., K. D. Erttmann, and M. Y. Gallin. 1996. Host-parasite interaction in human onchocerciasis: identification and sequence analysis of a novel human calgranulin. Biochem. Biophys. Res. Commun. 221:454-458.
18. + cytotoxic T-cell responses during chronic viral infection. J. Virol. 68:8056-8063.
19. McCormick, J. B., I. J. King, P. A. Webb, K. M. Johnson, R. O'Sullivan, and E. S. Smith. 1987. A case-control study of the clinical diagnosis and course of Lassa fever. J. Infect. Dis. 155:445-455.
20. McCormick, J. B., P. A. Webb, J. W. Krebs, K. M. Johnson, and E. S. Smith. 1987. A prospective study of the epidemiology and ecology of Lassa fever. J. Infect. Dis. 155:437-444.
21. Morrison, H. G., S. P. Bauer, J. V. Lange, J. J. Esposito, J. B. McCormick, and D. D. Auperin. 1989. Protection of guinea pigs from Lassa fever by vaccinia virus recombinants expressing the nucleoprotein or the envelope glycoproteins of Lassa virus. Virology 171:179-188.
22. Murali-Krishna, K., J. D. Altmann, M. Suresh, D. J. D. Sourdrive, A. J. Zajac, J. D. Miller, J. Slansky, and R. Ahmed. 1998. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity 8:177-187.
23. Oxenius, A., K. A. Campbell, C. R. Maliszewski, T. Kishimoto, H. Kikutani, H. Hengartner, R. M. Zinkernagel, and M. F. Bachmann. 1996. CD40-CD40 ligand interactions are critical in T-B cooperation but not for other anti-viral CD4+ T cell functions. J. Exp. Med. 183:2209-2218.
24. Pawelec, G., A. Ziegler, and P. Wernet. 1985. Dissection of human allostimulatory determinants with cloned T cells: stimulation inhibition by monoclonal antibodies TU 22, 34, 36, 37, 39, 43 and 58 against distinct human MHC class 11 molecules. Hum. Immunol. 12:165.
25. Planz, O., P. Seiler, H. Hengartner, and R. M. Zinkernagel. 1996. Specific cytotoxic T cells eliminate B cells producing virus-neutralizing antibodies. Nature 382:726-729.
26. ter Meulen, J., I. Lukashevich, K. Sidibe, A. Inapogui, M. Marx, A. Dörlemann, M. L. Yansane, K. Koulemou, J. Chang-Claude, and H. Schmitz. 1996. Hunting of peridomestic rodents and consumption of their meat as possible risk factors for rodent-to-human transmission of Lassa virus in the Republic of Guinea. Am. J. Trop. Med. Hyg. 55:661-666.
27. ter Meulen, J., K. Koulemou, T. Wittekindt, K. Windisch, S. Strigl, S. Conde, and H. Schmitz. 1998. Detection of Lassa virus antinucleoprotein immunoglobulin G (IgG) and IgM antibodies with a simple recombinant immunoblot assay for field use. J. Clin. Microbiol. 36:3143-3148.
28. Tomori, O., K. M. Johnson, M. P. Kiley, and L. H. Elliot. 1987. Standardization of a plaque assay for Lassa virus. J. Med. Virol. 22:77-89.
29. Varga, S. M., and R. M. Welsh. 1998. Stability of virus-specific CD4+ T cell frequencies from acute infection into long term memory. J. Immunol. 161: 367-374.
30. von Herrath, M. G., M. Yokoyama, J. Dockter, M. B. Oldstone, and J. L. Whitton. 1996. CD4-deficient mice have reduced levels of memory cytotoxic T lymphocytes after immunization and show diminished resistance to subsequent viral challenge. J. Virol. 70:1072-1079.
31. Wang, H., and D. D. Eckels. 1999. Mutations in immunodominant T cell epitopes derived from the nonstructural 3 protein of hepatitis C virus have the potential for generating escape variants that may have important consequences for T cell recognition. J. Immunol. 162:4177-4183.
32. 2 memory following acute lymphocytic choriomeningitis virus infection. J. Virol. 72:8281-8288.
33. Zajac, A. J., J. N. Blattmann, K. Murali-Krishna, D. J. D. Sourdive, M. Suresh, J. D. Altmann, and R. Ahmed. 1998. Viral immune evasion due to persistence of activated T cells without effector function. J. Exp. Med. 188: 2205-2213.